{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T17:47:19Z","timestamp":1746208039008},"reference-count":19,"publisher":"Japanese Society of Internal Medicine","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2005]]},"DOI":"10.2169\/internalmedicine.44.757","type":"journal-article","created":{"date-parts":[[2005,8,8]],"date-time":"2005-08-08T07:48:06Z","timestamp":1123487286000},"page":"757-760","source":"Crossref","is-referenced-by-count":3,"title":["Rapidly Progressed Acquired Immunodeficiency Syndrome Dementia Complex as an Initial Manifestation"],"prefix":"10.2169","volume":"44","author":[{"given":"Makoto","family":"TAKEUCHI","sequence":"first","affiliation":[{"name":"Department of Hematology, National Hospital Organization, Minami-Okayama Medical Center, Okayama"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keigo","family":"NOBUKUNI","sequence":"additional","affiliation":[{"name":"Neurology, National Hospital Organization, Minami-Okayama Medical Center, Okayama"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"TAKATA","sequence":"additional","affiliation":[{"name":"Neurology, National Hospital Organization, Minami-Okayama Medical Center, Okayama"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriko","family":"KAWATA","sequence":"additional","affiliation":[{"name":"Internal Medicine, National Hospital Organization, Minami-Okayama Medical Center, Okayama"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriko","family":"HAYASHIBARA","sequence":"additional","affiliation":[{"name":"Radiology, National Hospital Organization, Minami-Okayama Medical Center, Okayama"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"ISHIZU","sequence":"additional","affiliation":[{"name":"Department of Neurology, Okayama University Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoshi","family":"TAKAHASHI","sequence":"additional","affiliation":[{"name":"Internal Medicine, National Hospital Organization, Minami-Okayama Medical Center, Okayama"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Budka H. Human immunodeficiency virus (HIV)-induced disease of the central nervous system: pathology and implications for pathogenesis. Acta Neuropathol Berl 77<\/b>: 225-236, 1989.","DOI":"10.1007\/BF00687573"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Price R. The cellular basis of central nervous system HIV-1 infection and the AIDS dementia complex: Introduction. J Neuro-AIDS 1<\/b>: 1-28, 1995.","DOI":"10.1300\/J128v01n01_01"},{"key":"3","unstructured":"3) Price RW. Understanding the AIDS dementia complex (ADC). The challenge of HIV and its effects on the central nervous system. Res Publ-Assoc Res Nerv Ment Dis 72<\/b>: 1-45, 1994."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Nuovo G, Alfieri M. AIDS dementia is associated with massive, activated HIV-1 infection and concommitant expression of several cytokines. Mol Med 2<\/b>: 358-366, 1996.","DOI":"10.1007\/BF03401633"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410330502"},{"key":"6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199504063321407"},{"key":"7","unstructured":"7) Lewis PR. Merritt’s Nuerology Tenth Edition. Lippincott Williams & Wilkins, Philadelphia, 2000: 163-175."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Neuenburg JK, Brodt HR, Herndier BG, et al. HIV-related neuropathology, 1985 to 1999: rising prevalence of HIV encephalopathy in the era of highly active antiretroviral therapy. J Acquir Immune Defic Syndr 31<\/b>: 171-177, 2002.","DOI":"10.1097\/00126334-200210010-00007"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Dore GJ, McDonald A, Li Y, Kaldor JM, Brew BJ. National HIV Surveillance Committee. Marked improvement in survival following AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS 17<\/b>: 1539-1545, 2003.","DOI":"10.1097\/00002030-200307040-00015"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Aweeka F, Jayewardene A, Staprans S, et al. Failure to detect nelfinavir in the cerebrospinal fluid of HIV-1-infected patients with and without AIDS dementia complex. J Acquir Immune Defic Syndr Hum Retrovirol 20<\/b>: 39-43, 1999.","DOI":"10.1097\/00042560-199901010-00006"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Kedzierska K, Crowe SM. The role of monocytes and macrophages in the pathogenesis of HIV-1 infection. Curr Med Chem 9<\/b>: 1893-1903, 2002.","DOI":"10.2174\/0929867023368935"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Schmitt F, Bigley J, McKinnis R, Logue PE, Evans RW, Drucker JL. Neuropsychological outcome of zidovudine (AZT) treatment of AIDS and AIDS-related complex. N Engl J Med 319<\/b>: 1573-1578, 1988.","DOI":"10.1056\/NEJM198812153192404"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Baldeweg T, Catalan J, Lovett E, Gruzelier J, Riccio M, Hawkins D. Long-term zidovudine reduces neurocognitive deficits in HIV-1 infection. AIDS 9<\/b>: 589-596, 1995.","DOI":"10.1097\/00002030-199506000-00010"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Burger D, Kraaijeveld C, Meenhorst P, et al. Penetration of zidovudine into the cerebrospinal fluid of patients infected with HIV. AIDS 7<\/b>: 1581-1587, 1993.","DOI":"10.1097\/00002030-199312000-00006"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Sacktor NC, Skolasky RL, Lyles RH, Esposito D, Selnes OA, McArthur JC. Improvement in HIV-associated motor slowing after antiretroviral therapy including protease inhibitors. J Neurovirol 6<\/b>: 84-88, 2000.","DOI":"10.3109\/13550280009006385"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Sacktor NC, Lyles RH, Skolasky RL, et al. Combination antiretroviral therapy improves psychomotor speed performance in HIV-seropositive homosexual men. Multicenter AIDS Cohort Study (MACS). Neurology 52<\/b>: 1640-1647, 1999.","DOI":"10.1212\/WNL.52.8.1640"},{"key":"17","unstructured":"17) Yasuoka A, Genta I, Tanuma J, et al. Trends of HIV-related opportunistic infection in the era of highly active anti-retroviral therapy at the AIDS Clinical Center, Japan. Research report on the therapy for opportunistic infections. Japanese Ministry of Health, Welfare and Labor. 2002: 17-23 (in Japanese)."},{"key":"18","unstructured":"18) Thurnher MM, Schindler EG, Thurnher SA, Pernerstorfer-Schon H, Kleibl-Popov C, Rieger A. Highly active antiretroviral therapy for patients with AIDS dementia complex: effect on MR imaging findings and clinical course. AJNR Am J Neuroradiol 21<\/b>: 670-678, 2000."},{"key":"19","unstructured":"19) Post MJD, Levin BE, Berger JR, Duncan R, Quencer RM, Calabro G. Sequential cranial MR findings of asymptomatic and neurologically symptomatic HIV+ subjects. AJNR Am J Neuroradiol 13<\/b>: 359-370, 1992."}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/44\/7\/44_7_757\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T17:24:22Z","timestamp":1621445062000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/44\/7\/44_7_757\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005]]},"references-count":19,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2005]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.44.757","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005]]}}}